Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility

References

• Mitwally M, Casper R. Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001; 75: 305–9
   PubMed Web of Science ®Google Scholar
• Bayar U, Tanriverdi HA, Aykut B, Ayoğlu F, Özcan O, Erdal K. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006; 85: 1045–8
   PubMed Web of Science ®Google Scholar
• Al-Fozan H, Al-Khadouri M, Tang SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004; 82: 1561–3
   PubMed Web of Science ®Google Scholar
• Mitwally M, Casper R. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril. 2002; 77: 776–80
   PubMed Web of Science ®Google Scholar
• Healey S, Tan SL, Tulandi T, Biljan M. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril. 2003; 80: 1325–9
   PubMed Web of Science ®Google Scholar
• Byung CJ, Seung YK, Chang SS, Ki CK, Won DL. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril. 2006; 85: 1774–7
   PubMed Web of Science ®Google Scholar
• Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril. 2005;84( supp. 1): O-231, Abstract 1033.
   Web of Science ®Google Scholar
• Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod. 1990; 5: 670–4
   PubMed Web of Science ®Google Scholar
• Yagel S, Ben-Chetrit A, Anteby E, Zacut D, Hochner-Celnikier D, Ron M. The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate. Fertil Steril. 1992; 57: 33–6
   PubMed Web of Science ®Google Scholar
• Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993; 59: 756–60
   PubMed Web of Science ®Google Scholar
• Badawy A, Abdel All I, Abu Elatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome? A prospective randomized trial. Fertility & Sterility Online. 19 June 2007 ( 2007.02.062).
   Google Scholar
• Badawy A, Abdel All I Abu Elatta M. Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovarian syndrome? A prospective controlled trial. Fertil Steril. 2007 ( In press).
   Google Scholar
• Varma TR, Patel RH, Bhathenia RK. Outcome of pregnancy after infertility. Acta Obstet Gynecol Scand. 1988; 67: 115–19
   PubMed Web of Science ®Google Scholar
• Hill GA, Bryan S, Herbert CM 3rd, Shah DM, Wentz AC. Complications of pregnancy in infertile couples: routine treatment versus assisted reproduction. Obstet Gynecol. 1990; 75: 790–4
   PubMed Web of Science ®Google Scholar
• Fontana PG, Leclerc JM. Contraindication of Femara® (letrozole) in premenopausal women. http://www.ca.novartis.com/downloads/en/letters/femara-hcp-e-17-11 05.pdf.
   Google Scholar
• Luthra R, Kirma N, Jones J, Tekmal RR. Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice. J Steroid Biochem Mol Biol. 2003; 86: 461–7
   PubMed Web of Science ®Google Scholar
• Mitwally M, Biljan M, Casper R. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol. 2005; 192: 381–6
   PubMed Web of Science ®Google Scholar
• Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fetil Steril. 2006; 85: 1761–5
   PubMed Web of Science ®Google Scholar
• Bishai R, Arbour L, Lyons C, Koren G. Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. Teratology. 1999; 60: 143–5
   PubMedGoogle Scholar
• Physicians Desk Reference PDR. 55th ed. Anastrozole. Montvale, NJ: Medical Economics Company Inc.; 2001. 662–85.
   Google Scholar
• Hu Y, Cortvrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev. 2002; 61: 549–59
   PubMed Web of Science ®Google Scholar